Through April 30, there will be free, guided tours at 400 of the company’s stores with in-store pharmacies under the Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, ACME, Tom Thumb, Randalls, Pavilions, Star Market and Carrs banners.
EcoTools is partnering with actress Vanessa Hudgens on its #MyTrueBeauty campaign, a mobile tour that will allow guests to see EcoTools’ New Modern Eco collection and learn from makeup artists and experts about various makeup application areas.
H.R. 749 is intended to require the U.S. Food and Drug Administration to act upon applications for generic drugs within 180 days of being filed that are in short supply or when there are too few manufacturers on the market is being revised.
Some 83% of patients with chronic myelogenous leukemia taking Gleevec (imatinib) can live 10 years or longer, according to new data published in the New England Journal of Medicine, NBC News is reporting. The study looked at the original 1,100 patients in the Gleevec trial, though in the years since approval several generics have hit the market. The data shows the drug, which targets a CML-specific genetic mutation, has a 10-year survival rate of nearly 83%. (NBC News)
The brand said it’s dedicated to using 100%natural ingredients in its products — which include such bestsellers as beard oils, beard balms and mustache wax, as well as complete care kits that include brushes and combs.
Kroger is developing a $60 million distribution center in Cincinnati, the Cincinnati Business Courier reported Tuesday. “More than 8.5 million customers shop in our stores every day and our goal is to always have our shelves stocked with the variety and selection our shoppers want,” stated Frank Bruni, VP supply chain and logistics, Kroger. “The new facility will help our logistics team to improve lead times and drive efficiencies for our stores and ultimately our customers.” (Cincinnati Business Courier)
Wall Street investors have faith that the Federal Trade Commission will approve Walgreens Boots Alliance’s proposed acquisition of Rite Aid — and that’s having a positive influence on Walgreens’ stock, according to Crain’s Chicago Business. WBA’s shares have been up 6% this year and up 19% over March 2016, which Morningstar analyst Vishnu Lekraj says is due to “investor optimism that they’re going to be able to close the Rite Aid transaction.” (Crain’s Chicago Business)